Met Antibody

Skip to product information
1 of 3

Selleck Chemicals

SKU:F0288-20UL

Regular price €169,00 EUR
Regular price Sale price €169,00 EUR
Sale Sold out
Taxes included. Shipping calculated at checkout.
Size
Quantity
View full details

About the Target

The Met tyrosine kinase, encoded by the c-met proto-oncogene, acts as the high-affinity receptor for hepatocyte growth factor (HGF). Comprising a 50-kDa α-subunit and a 145-kDa β-subunit, linked by a disulfide bond, Met plays crucial roles in both embryo development and tumor invasion. HGF, existing as a mature α/β heterodimer, contains a high-affinity Met-binding site in the α-chain (HGF-α) and a low-affinity Met-binding site in the β-chain (HGF-β). Depending on the literature source, MET may also be discussed as c-Met.

Reported cellular context includes membrane and secreted, which can matter when signal is compared across treatments or changing cell states. Following MET across matched perturbations can help separate abundance effects from shifts in localization, complex assembly, or pathway state.

Research Context

MET is commonly interpreted in the context of cancer, developmental biology, and cell signaling research, and readouts are often stronger when a study separates expression changes from compartment-level redistribution. When reported signal spans membrane and secreted, a defined reference condition can make comparisons more interpretable across perturbations, passages, or replicate sets.

Consider these angles when interpreting target-level changes:

  • apparent redistribution between membrane and secreted across matched conditions
  • changes associated with proliferative state, oncogenic signaling, or treatment response
  • stage-dependent patterns during differentiation, morphogenesis, or lineage commitment
  • signal-dependent shifts after ligand, inhibitor, or growth-factor perturbation

Variant Considerations

If your project spans exploratory questions, the regular version offers a balanced option for establishing baseline signal behavior for MET. This can help when protocols evolve over time and the goal is to compare experiments using a stable reference workflow.

Standardize sampling time, control choice, and downstream analysis thresholds so apparent differences in MET reflect biology rather than handling. When interpreting MET, it is often useful to decide early whether the main question is overall abundance, compartmental enrichment, or context-dependent redistribution.

For multi-run studies, a shared reference condition can keep MET trends easier to compare across datasets. That kind of consistency is especially helpful when follow-up work expands to new perturbations, model systems, or longitudinal collections.

Targets:
MET
Research Area:
Cancer • Cell Signaling • Developmental Biology
Application:
FCM • IF • IHC • IP • WB
Reactivity:
Human
Specificity:
Met Antibody [L21L21] recognizes endogenous levels of total Met protein.
Host:
Rabbit
Clonality:
Monoclonal
Clone:
L21L21
UniProt:
P08581
Storage Buffer:
PBS, pH 7.2+50% Glycerol+0.05% BSA+0.01% NaN₃
Storage Temperature:
-20°C

For Research Use Only. Not intended for diagnostic or therapeutic use.
Products may be subject to intellectual property rights.

The purchase of this product does not grant any license for commercial use, manufacturing, or clinical applications. The user is responsible for ensuring compliance with applicable laws and third-party rights.